top of page

🗓️ When is iPHEX Held?

iPHEX is typically organized annually by the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL), under the Ministry of Commerce and Industry. The dates and venue vary each year, rotating among major Indian cities like Mumbai, Hyderabad, and New Delhi.

For 2025, the specific dates and venue will be officially announced by PHARMEXCIL on their official website. It's recommended to check regularly or subscribe for updates to stay informed.


iPHEX

🌍 Exploring Emerging Markets Through IPHEX: LATAM, Africa, ROW, and Beyond


One of the key strengths of iPHEX India is its strategic focus on emerging and underserved international markets, also known as the Rest of the World (ROW) markets. These include regions like:


🌎 LATAM (Latin America)

Countries like Brazil, Mexico, Colombia, and Peru are rapidly growing markets with increasing demand for affordable generic medicines and vaccines. Through iPHEX, Indian pharma exporters gain access to regulators and buyers from this region, facilitating faster entry and stronger partnerships.


🌍 Africa

Africa’s pharmaceutical market is projected to exceed $60 billion by 2030. iPHEX promotes Indian pharma as a trusted partner in supplying affordable, quality-assured medicines for diseases like malaria, HIV/AIDS, tuberculosis, and non-communicable diseases.


🌏 ROW (Rest of the World) – Including CIS, Southeast Asia, and Middle East

Many ROW markets have regulatory pathways compatible with Indian standards (like WHO-GMP), making them attractive for Indian exporters. iPHEX encourages business development in:

  • CIS countries (Kazakhstan, Uzbekistan, etc.)

  • ASEAN countries (Vietnam, Indonesia, Philippines)

  • Middle East and GCC nations (UAE, Saudi Arabia, Oman)


🌐 Why These Markets Matter

  • Less Saturation: Unlike the US and EU, emerging markets are less competitive and more open to new suppliers.

  • Growing Demand: Increasing healthcare budgets and expanding insurance coverage create high demand for generics.

  • Regulatory Synergy: Many countries recognize Indian regulatory certifications, easing entry barriers.


🚀 iPHEX: Gateway to Global Growth


By inviting delegates, regulators, and procurement officials from these emerging regions, iPHEX helps Indian pharma companies:

  • Build trust and transparency

  • Understand market-specific needs

  • Forge direct business relationships

  • Sign export deals and MOUs


In essence, iPHEX is not just a showcase—it’s a strategic export accelerator into tomorrow’s most promising pharma markets.

Comments

bottom of page